Apyx Medical (APYX) Competitors $2.06 +0.07 (+3.25%) As of 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APYX vs. SKIN, CATX, OM, TLSI, MGRM, SI, INGN, STIM, NNOX, and INFUShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include Beauty Health (SKIN), Perspective Therapeutics (CATX), Outset Medical (OM), TriSalus Life Sciences (TLSI), Monogram Orthopaedics (MGRM), Shoulder Innovations (SI), Inogen (INGN), Neuronetics (STIM), Nano-X Imaging (NNOX), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Its Competitors Beauty Health Perspective Therapeutics Outset Medical TriSalus Life Sciences Monogram Orthopaedics Shoulder Innovations Inogen Neuronetics Nano-X Imaging InfuSystem Beauty Health (NASDAQ:SKIN) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability. Is SKIN or APYX more profitable? Beauty Health has a net margin of -6.13% compared to Apyx Medical's net margin of -37.11%. Beauty Health's return on equity of -32.82% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Beauty Health-6.13% -32.82% -2.96% Apyx Medical -37.11%-158.22%-28.30% Which has better valuation and earnings, SKIN or APYX? Apyx Medical has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeauty Health$334.30M0.97-$29.10M-$0.28-9.09Apyx Medical$48.10M1.62-$23.46M-$0.45-4.59 Do analysts rate SKIN or APYX? Beauty Health presently has a consensus target price of $2.63, suggesting a potential upside of 3.14%. Given Beauty Health's higher possible upside, equities research analysts plainly believe Beauty Health is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Does the media refer more to SKIN or APYX? In the previous week, Beauty Health had 13 more articles in the media than Apyx Medical. MarketBeat recorded 15 mentions for Beauty Health and 2 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.45 beat Beauty Health's score of 0.96 indicating that Apyx Medical is being referred to more favorably in the news media. Company Overall Sentiment Beauty Health Positive Apyx Medical Positive Which has more volatility & risk, SKIN or APYX? Beauty Health has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Do insiders and institutionals believe in SKIN or APYX? 93.3% of Beauty Health shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 41.0% of Beauty Health shares are held by company insiders. Comparatively, 15.2% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryBeauty Health beats Apyx Medical on 9 of the 16 factors compared between the two stocks. Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$78.10M$10.66B$5.82B$10.17BDividend YieldN/A1.85%5.69%4.60%P/E Ratio-4.5921.1374.6725.98Price / Sales1.6229.47454.5485.61Price / CashN/A24.7237.0859.91Price / Book5.433.5212.186.31Net Income-$23.46M$210.50M$3.29B$270.86M7 Day Performance5.36%-0.12%1.08%3.46%1 Month Performance-7.81%4.01%7.32%6.57%1 Year Performance66.53%-9.96%63.11%28.39% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical2.4923 of 5 stars$2.07+3.3%N/A+60.0%$78.10M$48.10M-4.59270Positive NewsShort Interest ↓Gap DownSKINBeauty Health0.5611 of 5 stars$2.33+13.7%$2.63+12.7%+72.7%$259.99M$334.30M-8.321,030CATXPerspective Therapeutics1.7335 of 5 stars$3.43-0.9%$12.56+266.1%-78.4%$254.72MN/A0.0070OMOutset Medical2.3066 of 5 stars$13.81-1.4%$24.67+78.6%+85.0%$248.90M$113.69M-0.68520Positive NewsTLSITriSalus Life Sciences2.9545 of 5 stars$5.01+0.4%$10.75+114.6%-6.6%$248.84M$29.43M-4.25106Positive NewsMGRMMonogram Orthopaedics1.8619 of 5 stars$5.75+0.7%$5.40-6.1%+70.5%$232.01MN/A-11.5028Positive NewsShort Interest ↓SIShoulder Innovations3.3377 of 5 stars$16.03+7.9%$19.60+22.3%N/A$226.14MN/A-0.5461News CoverageAnalyst ForecastQuiet Period ExpirationINGNInogen4.184 of 5 stars$8.45+4.2%$11.00+30.2%-26.0%$219.29M$343.47M-7.971,030Positive NewsSTIMNeuronetics2.0594 of 5 stars$3.37+4.3%$7.00+107.7%+366.2%$213.58M$74.89M-2.98180Positive NewsNNOXNano-X Imaging2.9597 of 5 stars$4.02+8.9%$8.50+111.4%-36.0%$213.21M$11.28M-4.47190Positive NewsINFUInfuSystem3.3603 of 5 stars$10.26+1.0%$12.50+21.8%+55.8%$209.57M$139.89M171.03410Positive News Related Companies and Tools Related Companies SKIN Competitors CATX Competitors OM Competitors TLSI Competitors MGRM Competitors SI Competitors INGN Competitors STIM Competitors NNOX Competitors INFU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APYX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCollege grad makes $64,000 a monthNothing hurts like a missed opportunity... And with AI stocks like Nvidia, Palantir, and Oracle continuing...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
